[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트

 

구분	보고서 (영문)
제약/바이오/임 상시험	Takeda’s Eohilia to Compete Sanofi’s Dupixent in Eosinophilic Esophagitis Treatment
	eConsent: The Overlooked Patient-Centric Tool
	The Magrolimab Trial Halt Highlights the Uncertainties in Anti-CD47 Immunotherapy
	The Tiny Pills That May Send Shockwaves Across Immunology
	Cell and Gene Therapy Landscape in the US
	Another Setback for Minerva’s Schizophrenia Treatment Roluperidone
	APAC Led in Trials for 2023, with the Majority in Phase II
	Oncology Emerges as Dominant Therapy Area for CRISPR Technology
	Allecra’s EXBLIFEP Provides Valuable New Weapon to Tackle ESBL Mediated AMR
	AbbVie and Genmab’s Epkinly Joins BiTE Competition in Follicular Lymphoma
질환별	Comorbidities Associated with ADHD Present an Opportunity for Pipeline Products to Capture the Market
	Female Sexual Dysfunction: Competitive Landscape
	Shifting the Paradigm – Novel Approaches to Amyotrophic Lateral Sclerosis Therapy
	Cell & Gene Therapies in Hemophilia A & B
	Shifting Patterns in Cervical Cancer Cases in Women in Their 30s and 40s
컨퍼런스/심포 지엄/학회/기타	IO360: First Allogeneic Dual CAR T-Cell Therapy Shows Promise in B Cell Non-Hodgkin Lymphom
	Biotech Funding Optimism Rises as 44% Predict Recovery in 2024
	Market Cap Upturn for Top 20 Biopharma Companies with Obesity Drug Successes in 2023
	AD/PD 2024: The Role of Blood-Based Biomarkers in Alzheimer’s Disease
	AD/PD 2024: Promising Data for Monitoring Speech Deficits in Early Parkinson’s